Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Terumo ( (JP:4543) ) has issued an announcement.
Terumo Corporation reported strong financial performance for the nine months ending December 31, 2024, with significant revenue and profit growth year-on-year. The company conducted a two-for-one share split, affecting earnings per share calculations, and maintained its dividend guidance, indicating stable financial management and potential positive implications for investors.
More about Terumo
Terumo Corporation is a company listed on the Tokyo Stock Exchange, primarily operating in the medical industry. It focuses on developing and manufacturing medical devices and products aimed at improving healthcare and patient outcomes.
YTD Price Performance: -12.16%
Average Trading Volume: 4,103
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $26.85B
Find detailed analytics on 4543 stock on TipRanks’ Stock Analysis page.
